Fundraising FoxQatar Investment Authority — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Codiakbiocodiakbio.comNov 2017
Cambridge, MA clinical-stage biotech developing engineered exosome therapeutics; IPO'd on NASDAQ in 2020, later restructured.
BiotechSeattle, US
Doug Williams(Executive Officer, Director)in
BoardNoubar Afeyan(Director)inSteven Gillis(Director)Eric Lander(Director)
Co-investorsARCH Venture PartnersEcoR1 CapitalAlexandriaFidelity InvestmentsFlagship Pioneering
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.